Wasp venom allergy immunotherapy (Allergopharma)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameWasp venom allergy immunotherapy (Allergopharma)
Drug Alias NameWasp venom allergy vaccine黄蜂毒液过敏免疫疗法 - Allergopharma
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergopharma Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A